These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 20617750)

  • 1. [Axial spondyloarthritis and ankylosing spondylitis].
    Nordström D; Kauppi M
    Duodecim; 2010; 126(12):1467-74. PubMed ID: 20617750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ankylosing spondylitis and undifferentiated spondyloarthritis with TNF alpha-antagonists].
    Brandt J; Sieper J; Braun J
    Z Rheumatol; 2003 Jun; 62(3):218-27. PubMed ID: 12827397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
    van der Heijde D; Sieper J; Maksymowych WP; Dougados M; Burgos-Vargas R; Landewé R; Rudwaleit M; Braun J;
    Ann Rheum Dis; 2011 Jun; 70(6):905-8. PubMed ID: 21540200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
    Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
    Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The classification and diagnostic criteria of ankylosing spondylitis.
    Raychaudhuri SP; Deodhar A
    J Autoimmun; 2014; 48-49():128-33. PubMed ID: 24534717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early spondyloarthritis.
    Poddubnyy D; Rudwaleit M
    Rheum Dis Clin North Am; 2012 May; 38(2):387-403. PubMed ID: 22819091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
    Haibel H; Sieper J
    Curr Opin Rheumatol; 2010 Jul; 22(4):388-92. PubMed ID: 20473176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
    Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
    Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
    Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis.
    Robinson PC; Benham H
    Intern Med J; 2015 Feb; 45(2):127-33. PubMed ID: 25132517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of ankylosing spondylitis].
    Pavelka K
    Vnitr Lek; 2006; 52(7-8):726-9. PubMed ID: 16967615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
    Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
    J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results.
    Bedaiwi MK; AlRasheed RF; Bin Zuair A; Alqurtas EM; Baeshen MO; Omair MA
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5241-5247. PubMed ID: 34486699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging in inflammatory spine diseases].
    Theumann N; Aubry-Rozier B; Guntern D
    Rev Med Suisse; 2009 Mar; 5(194):566, 568-70. PubMed ID: 19405271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutics for spondyloarthritis.
    Toussirot É
    Expert Opin Pharmacother; 2011 Nov; 12(16):2469-77. PubMed ID: 21988214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?
    Sieper J; Rudwaleit M
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv61-4. PubMed ID: 16239391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.